Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000199874 | SCV000250997 | benign | not specified | 2014-08-14 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Illumina Laboratory Services, |
RCV000349973 | SCV000482755 | likely benign | Sideroblastic Anemia and Ataxia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000676905 | SCV001150379 | uncertain significance | not provided | 2016-06-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000676905 | SCV002407754 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000676905 | SCV000802720 | uncertain significance | not provided | 2016-02-23 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003977541 | SCV004795410 | likely benign | ABCB7-related disorder | 2020-01-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |